Understanding Amgen's Options Market Trends
In recent times, significant investors have shown a notably bearish sentiment towards Amgen.
By analyzing the options history surrounding Amgen (NASDAQ: AMGN), there were 28 recorded trades that shed light on investor inclinations.
Delving deeper into the specifics, only 42% of investors opened trades with optimistic expectations while a fair 46% leaned towards pessimism.
Among these trades, 16 were puts, accounting for a substantial $2,256,910 in trades, whereas 12 were calls, amassing $503,085.
Key Price Expectations
The trade activities suggest that influential investors have set their sights on a price range for Amgen stretching from $185.0 to $380.0 over the past quarter.
Volume and Open Interest Insights
Surveying the volume and open interest provides essential insight into the demand and liquidity surrounding Amgen's options. This data is vital for understanding investor interest at various strike prices. Here’s an overview of trends in volume and open interest related to both call and put options.
Recent Options Activity for Amgen
Let’s explore notable recent options activity:
Highlighted Options Transactions
During the past month, several noteworthy options trades were executed:
Symbol: AMGN | Trade Type: PUT | Sentiment: BEARISH | Expiration Date: 11/15/24 | Total Trade Price: $1.2M | Volume: 5.1K
Symbol: AMGN | Trade Type: PUT | Sentiment: BEARISH | Expiration Date: 01/17/25 | Total Trade Price: $148.9K | Volume: 17
Symbol: AMGN | Trade Type: PUT | Sentiment: BULLISH | Expiration Date: 11/15/24 | Total Trade Price: $131.5K | Volume: 567
Symbol: AMGN | Trade Type: PUT | Sentiment: BEARISH | Expiration Date: 12/20/24 | Total Trade Price: $117.0K | Volume: 88
About Amgen
Amgen is a major player in the arena of biotechnology-driven human therapeutics. Their well-regarded products include red blood cell enhancers like Epogen and Aranesp, alongside immune boosters Neupogen and Neulasta, and drugs for inflammatory conditions such as Enbrel and Otezla. With a strong commitment to innovation, Amgen launched its inaugural cancer treatment, Vectibix, back in 2006, followed by bone-enhancing medications Prolia/Xgeva and Evenity in more recent years. The acquisition of Onyx enhanced their oncology offerings with Kyprolis. Newer introductions include Repatha, Aimovig, Lumakras, and Tezspire.
Current Market Status of Amgen
- Currently, Amgen's volume stands at 1,450,738 with a price drop of -1.49% resting at $314.9.
- Relative Strength Index (RSI) indicators suggest that the stock is in a neutral territory, neither overbought nor oversold.
- Upcoming earnings are anticipated to be disclosed within the week.
Professional Insight on Amgen
In the last month, five analysts have shared their perspectives on Amgen, establishing an average price target set at $348.2.
Trading strategy note: In a recent move, an analyst downgraded the stock to Overweight with a price target of $405. Another analyst has also adjusted their rating down to Hold with a price target of $333.
Staying Informed on Amgen's Market Dynamics
While trading options may carry higher inherent risks, there is also potential for notable profits. Traders adept at navigating these waters focus on continuous education, strategic adjustments, and utilizing multimedia indicators. Regularly monitoring Amgen’s trading activity can enhance your investment strategy and responsiveness.
Frequently Asked Questions
What are the current market sentiments regarding Amgen?
There is a noticeable bearish sentiment from significant investors based on recent trading activities, with more puts than calls observed.
What is Amgen's average price target based on recent analyses?
The average price target set by analysts within the last month for Amgen is approximately $348.2.
How much has Amgen's stock price changed lately?
Amgen's stock has recently declined by -1.49%, currently priced at $314.9.
What kinds of options trades were highlighted?
Significant trades include bearish put options with a substantial total trade price, underscoring the cautious outlook on the stock.
How can I stay updated on Amgen's trading activities?
By monitoring market news and specialized trading platforms, investors can receive real-time alerts and updates on Amgen's stock performance.
